LINC01686: A Potential Drug Target and Biomarker (G284648)

Target Name: LINC01686

NCBI ID: G284648

LINC01686

Other Name(s): Long intergenic non-protein coding RNA 1686 | long intergenic non-protein coding RNA 1686

LINC01686: A Potential Drug Target and Biomarker

LINC01686 is a long intergenic non-protein coding RNA (lncRNA) molecule that has been identified using RNA-seq technology. It is characterized by its unique 3'-end and 5'-end features, which give it a unique structure and function. LINC01686 is located in chromosome 6 and has been shown to play a role in various cellular processes, including cell growth, development, and metabolism.

Drug Target Potential

The potential drug targets for LINC01686 are numerous and varied. One of the main targets of LINC01686 is the regulation of cell growth and metabolism. LINC01686 has been shown to be involved in the regulation of various cellular processes, including cell cycle progression, apoptosis, and metabolism. It has been shown to play a role in the regulation of cell growth, cell division, and cell death.

Another potential drug target for LINC01686 is its role in the regulation of inflammation. LINC01686 has been shown to be involved in the regulation of various inflammatory processes, including inflammation, pain, and autoimmune diseases. It has been shown to play a role in the regulation of inflammation by modulating the activity of various cellular signaling pathways, including T-cell signaling, NF-kappa-B signaling, and PI3K signaling.

Biomarker Potential

LINC01686 has the potential to serve as a biomarker for various diseases, including cancer, cardiovascular disease, and neurological disorders. One of the main biomarkers for cancer is the expression of LINC01686, which has been shown to be downregulated in various cancer types. This suggests that LINC01686 may be a promising biomarker for cancer diagnosis and treatment.

Another potential biomarker for LINC01686 is its role in the regulation of cardiovascular disease. LINC01686 has been shown to be involved in the regulation of various cardiovascular processes, including heart rate, blood pressure, and cholesterol levels. It has been shown to play a role in the regulation of cardiovascular disease by modulating the activity of various cellular signaling pathways, including calcium signaling, PKA signaling, and NF-kappa-B signaling.

LINC01686 may also serve as a biomarker for neurological disorders. LINC01686 has been shown to be involved in the regulation of various neurological processes, including brain development, synaptic plasticity, and neurotransmission. It has been shown to play a role in the regulation of neurological disorders by modulating the activity of various cellular signaling pathways, including BDNF signaling, TrkB signaling, and NF-kappa-B signaling.

Conclusion

In conclusion, LINC01686 is a promising molecule with a wide range of potential drug targets and biomarkers. Its unique structure and function, as well as its involvement in various cellular processes, make it an attractive target for drug development. Further research is needed to fully understand the role of LINC01686 in various cellular processes and its potential as a drug target and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 1686

The "LINC01686 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01686 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets